In a preliminary study, the 24-hour urinary excretion of corticosteroid sulphates and free cortisol have been measured in a group of patients with breast cancer and compared with the excretion of the same compounds in a group of normal women of similar age. Excretion of corticosteroid sulphates in the breast cancer group was found to be markedly raised. In a small number of patients with localized cancer of sites other than the breast the level of corticosteroid sulphate was not raised. If proved metastases were present a noticeable rise was observed.
Introduction
The importance of the excretion of neutral 17-oxosteroids in breast cancer in the prediction of the responsiveness to endocrine gland ablation was first studied by Allen et al. (1957) . Since then a number of other workers have substantiated their findings (Bulbrook et al., 1960; Bulbrook et al., 1962a Bulbrook et al., , 1962b Kumaoka et al., 1968) . Bulbrook et al. (1964) described a derived formula, which they termed the "discriminant function," which expressed the values of 11-deoxy-17-oxosteroid excretion in relation to that of the 17-oxogenic steroids. Their work suggests that patients with a positive discriminant generally respond better to endocrine organ ablation than patients with a negative result. Some doubts have recently been expressed about the usefulness of the "discriminant function" in early breast cancer (Wade et al., 1969) or where there is abnormal thyroid function (Sneddon et al., 1968) .
Plasma studies have shown that patients with advanced breast cancer have levels of 17-oxogenic steroids which are greatly above the normal range, although such raised levels are virtually absent in patients with early disease (Deshpande et al., 1965) . Although urinary 17-oxosteroid and oxogenic steroid excretion has gained importance in the prognosis of the disease, no attempt appears to have been made to investigate the excretion of urinary corticosteroid sulphates and free cortisol despite the fact that the ability of breast cancer tissue to produce sulphated compounds has been well shown (Dao, 1969) .
In this preliminary study the excretion of corticosteroid sulphates and free cortisol has been studied in both normal women and women at the time of the diagnosis of breast The free cortisol was determined by competitive protein binding radioassay (Hsu and Bledsoe, 1970 It -has been conclusively shown that only these corticosteroids are capable of binding with the corticosteroid binding globulin obtained from late pregnancy plasma (Kolanowski and Pizarro, 1969; Ghosh et al., 1971) , the assay being carried out on an aliquot (0-2 ml) of a 24-hour specimen of urine. The sample was washed with 2 x 2-5 volumes of ethyl acetate to remove the free steroids. The steroidal sulphate conjugates were then extracted on two occasions with 10 volumes and 2-5 volumes of ethanol: acetone (2:1). The pooled extracts were evaporated in a centrifuge tube under nitrogen and selectively solvolysed for 18 hours at 37°C. The reagent mixture was then neutralized with pyridine and evaporated under a stream of nitrogen. The liberated steroids were dissolved in 0-2 ml of water and washed with 10 volumes of light petroleum. The corticosteroids were extracted with 10 volumes of dichloromethane, quantitation being carried out by the protein binding technique described for cortisol (Hsu and Bledsoe, 1970) . The values were expressed as ug of free steroid in 24 hours. This method of estimation, together with an assessment of its precision, accuracy, and specificity has been published elsewhere (Ghosh et al., 1972) .
Results
The daily output of corticosteroid sulphates and free cortisol in patients with breast cancer and in normal controls of a similar age is shown in fig. 1 costeroid sulphates and cortisol, from which the difference between the two experimental groups can easily be ascertained ( fig. 2) .
The clinical history and the output of corticosteroid sulphates and cortisol in patients who have been diagnosed to be suffering from cancer in sites other than the breast are summarized in table II.
Statistical analysis using the Student t test shows that there is a highly statistical difference between normal controls and breast cancer-t = 4-71 (0-05 > P > 0-02)-with respect to the excretion of corticosteroid sulphates, although the difference is only marginally significant with respect to cortisol-t = 1V73 (0-20 > P > 010).
Discussion
The aim of this study was to elucidate the possible relation between the excretion of corticosteroid sulphates and free cortisol and the occurence of carcinoma of the breast. Previous in-vitro work by Dao (1969) showed that some primary and metastatic cancer cells are able to form steroid sulphates.
The present results now indicate that there is a pronounced difference in corticosteroid sulphate output between normal women and women with carcinoma of the breast of similar age. It is not known if the tumour size or the presence or absence of local or distant spread affects the output or, indeed, if the excretion of such increased amounts are casually related to the tumour, although the work of Dao (1969) (Salih et al., 1972) .
The other group of patients with cancers other than in the breast (summarized in table II) also show significant variation in their output of corticosteroid sulphate. The patients with proved metastases appear to excrete large amounts of these conjugates whereas others with apparently localized lesions provide values within the normal range.
Case 1 showed a dramatic fall in corticosteroid sulphate excretion six days after bilateral oophorectomy for uterine cancer. This suggests that some cells of the primary tumour tissue or metastases possibly responsible for the synthesis of sulphate may also require oestrogens for their survival. A subsequent rise in output suggests the pos-sible presence of non-oestrogen dependent cells, which are perhaps more directly dependent on adrenal corticosteroids than on ovarian hormones for their growth and survival. In spite of therapy in case 1 the patient died 12 weeks later because of widespread carcinomatosis.
At this stage of the investigation neither the severity of the lesion at the time of diagnosis of carcinoma of the breast nor the possible correlation between corticosteroid sulphate excretion and prognosis have been considered. It is also evident that tumours other than in the breast excrete these compounds, particularly when metastases have recurred.
Further work is currently in progress to extend these findings.
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